What is MNZO stock price today?

MNZO (Manzo Pharmaceut) stock is trading at $0.00 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is MNZO stock going up or down today?

MNZO stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy MNZO stock now?

The decision to buy MNZO depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is MNZO a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for MNZO based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is MNZO stock overvalued or undervalued?

Use our DCF valuation calculator to determine if MNZO is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is MNZO's P/E ratio?

P/E ratio data for MNZO will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is MNZO's market cap?

MNZO (Manzo Pharmaceut) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is MNZO's price to book ratio?

Price-to-book ratio for MNZO is available on our dashboard along with other valuation metrics.

Does MNZO pay dividends?

MNZO does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is MNZO's dividend yield?

MNZO does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is MNZO stock a good long-term investment?

MNZO's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is MNZO's revenue growth rate?

Revenue growth data for MNZO is available on our dashboard with detailed financial statement analysis.

Profitability metrics for MNZO are available on our dashboard with complete income statement analysis.

What are the risks of investing in MNZO?

Key risks for MNZO include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does MNZO compare to its competitors?

Compare MNZO to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize MNZO's performance and positioning.

What is MNZO's stock price target for 2026?

Our AI model provides price targets for MNZO based on fundamental analysis: Bull case $0.00 (+30%), Base case $0.00 (+15%), Bear case $0.00 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about MNZO?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for MNZO. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is MNZO's next earnings report?

MNZO reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

MNZO - Manzo Pharmaceut

NYSE * Financial Services * Shell Companies

$0.00

+$0.00 (+0.00%)

About Manzo Pharmaceut

Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. was incorporated in 1980 and is based in Milford, Pennsylvania.

MNZO Key Statistics

Market Cap

$0.12M

000

Employees

How MNZO Compares to Peers

MNZO is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 5

Growth Rank

N/A

of 5

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
MNZO(This stock)	$115.95K	N/A	0%	0.0%	-
JPMJpmorgan Chase	$850.63B	15.6	0%	0.3%	vs JPM
BACBank Of	$386.81B	13.9	0%	0.3%	vs BAC
WFCWells Fargo	$277.43B	14.1	0%	0.3%	vs WFC
GSGoldman Sachs	$291.22B	18.8	0%	0.3%	vs GS
VVisa Inc	$633.59B	32.2	0%	0.5%	vs V

Manzo Pharmaceut Company Information

Headquarters: PO Box 107, Milford, PA, United States, 18337, undefined
Website: www.lactofreedom.com
Sector: Financial Services
Industry: Shell Companies

Data Updated: January 20, 2026 at 8:52 PM EST

Ready to invest in MNZO?

Commission-free trading available. Affiliate links.

Upcoming Events for MNZO

Dashboard

Enter a ticker to analyze